Perampanel clinical trials
Also written E2007 and Fycompa.
How each study uses perampanel is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the perampanel studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 22 Oct 2012 · FYCOMPA · NDA 202834 (FDA, Drugs@FDA)
- European Union
- 23 Jul 2012 · Fycompa · EMEA/H/C/002434 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
77 studies that test it; most in 2017 (8)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 6 |
| 2007 | 5 |
| 2008 | 6 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 5 |
| 2017 | 8 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 52 · Other 25
Eisai Inc. (32) · Eisai Co., Ltd. (11) · Eisai Limited (5) · Eisai Korea Inc. (2) · Humanis Saglık Anonim Sirketi (2) · Mayo Clinic (2) · Aya Mohammed Abdel Magid Abdel Hamid (1) · Dana-Farber Cancer Institute (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test perampanel.
- Apr 2027A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood EpilepsyPhase 2 · Eisai Inc.
- May 2027PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac ArrestPhase 2 · University of California, San Francisco
Studies
Open first, then newest update. How each study uses perampanel is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 77
- PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac ArrestRecruitingPhase 2University of California, San FranciscoNCT06401707Written as Perampanel
- Senicapoc and Perampanel for Newly Diagnosed GlioblastomaRecruitingEarly Phase 1Aarhus University HospitalNCT07284069Written as Perampanel
- A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood EpilepsyActive, not recruitingPhase 2Eisai Inc.NCT04015141Written as Perampanel Oral Suspension
- Efficacy and Safety of Perampanel in the Treatment of Refractory Status EpilepticusTerminatedPhase 4Wayne State UniversityNCT05684978Written as Perampanel
- Bioequivalence Assessment Between Two Perampanel Oral Suspension FormulationsCompletedPhase 1Aya Mohammed Abdel Magid Abdel HamidNCT06969963Written as Lepsiramp, 0.5 Mg/mL Oral Suspension
- A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic SeizuresCompletedPhase 4Eisai Korea Inc.NCT05533814Written as Perampanel
- Effect of Perampanel on Peritumoral Hyperexcitability in HGGCompletedPhase 1/2Dana-Farber Cancer InstituteNCT04497142Written as Perampanel
- Fycompa in Catamenial EpilepsyTerminatedPhase 4University of FloridaNCT05201703Written as Fycompa
- Bioequivalence Study of Perampanel Tablets 12 mgCompletedPhase 1Humanis Saglık Anonim SirketiNCT06450223Written as Perampanel 12 MG
- Bioequivalence Study of Perampanel Tablets 10 mgCompletedPhase 1Humanis Saglık Anonim SirketiNCT06450236Written as Perampanel 10 MG
- Perampanel Titration and Cognitive EffectsTerminatedPhase 4Kimford Jay MeadorNCT04417907Written as Perampanel 1 week titration
- Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With EpilepsyCompletedPhase 2Eisai Inc.NCT02914314Written as perampanel
- Perampanel Single Ascending Dose Transcranial Magnetic Stimulation Biomarker Study in Amyotrophic Lateral SclerosisCompletedEarly Phase 1Mayo ClinicNCT03793868Written as Perampanel
- Perampanel in Focal Status EpilepticusTerminatedPhase 3Assistance Publique - Hôpitaux de ParisNCT04309721Written as Perampanel
- Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol DependenceCompletedPhase 1/2Virginia Commonwealth UniversityNCT02120365Written as Perampanel
- Fycompa Titration Intervals and Effects on Retention RateCompletedPhase 4University of ArizonaNCT03457129Written as Perampanel Oral Tablet
- Effects of Perampanel on Neurophysiology Test PerimetersCompletedPhase 4Weill Medical College of Cornell UniversityNCT03653741Written as Perampanel 6 MG
- Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal EpilepsyTerminatedPhase 4Mayo ClinicNCT04650204Written as Perampanel
- A Clinical Trial to Evaluate the Safety and Efficacy of Fycompa in Subjects With Amyotrophic Lateral Sclerosis (ALS)TerminatedNot applicableStony Brook UniversityNCT03020797Written as Perampanel
- Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic SeizuresCompletedPhase 3Eisai Inc.NCT02849626Written as Perampanel
See all 77 studies that test perampanel →
Given beside what is tested · 4 — perampanel is usual care or a partner of the new treatment
- The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal EffectsRecruitingPhase 2Yale UniversityNCT05786066Written as Perampanel 6 MG
- Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine ResponseRecruitingPhase 1Yale UniversityNCT05915013Written as Perampanel
- Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response, Pilot TrialCompletedPhase 1Yale UniversityNCT03367533Written as Perampanel
- Open Label Pilot Study of Perampanel for the Treatment of Alcohol Use DisorderCompletedPhase 1/2Virginia Commonwealth UniversityNCT04502589Written as Perampanel Tablet
Codes
What other systems call perampanel · ClinicalTrials.gg INT005681
- MeSH (NLM) C551441perampanelConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) H821664NPKPERAMPANELConfirmed FDA, NLM, Wikidata
- RxNorm 1356552Confirmed FDA, Wikidata
- Wikidata Q868658perampanelConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C75029PerampanelOne source FDA
- DrugBank DB08883One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C551441 | perampanel | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | H821664NPK | PERAMPANEL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1356552 | — | Confirmed FDA, Wikidata |
| Wikidata | Q868658 | perampanel | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C75029 | Perampanel | One source FDA |
| DrugBank | DB08883 | — | One source Wikidata |
Also registered as perampanel hydrate (4:3) (UNII 8LIX22217M).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.